Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Q2 Earnings Update: Bluebird Bio (BLUE) And Regeneron (REGN)
Article By:
Rod Raynovich
Thursday, August 2, 2018 11:09 PM EST
Regeneron Pharmaceuticals (REGN) soared 7% to $397 on earnings beat with adjusted EPS of $5.45. Bluebird Bio (BLUE) was up 0.79% to $156.60 despite losses and lagging revenue.
Recession Is Coming! Not.
Article By:
Kevin Cook
Sunday, February 25, 2018 8:20 AM EST
We can bank on stocks continuing to "bubble up" over the next year and we need only keep a vigilant eye on the inflation/rates picture and economic data for early signs of trouble (of which I see few now).
How Bad Was The Biotech Selloff Last Week?
Article By:
Rod Raynovich
Sunday, February 4, 2018 5:30 PM EST
Biotech stocks got hit with a double whammy from concerns about high prices and disruption in healthcare from reform. But biotech investors made money last year and are still in the green for 2018 even after many stocks reported earnings.